Patent · US Active

Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

US12129303B2 · kind B2 · utility

1Cited by

29References

16Claims

0Family size

Assignee

Lassen Therapeutics, Inc. · US

Inventors

Robert A. Horlick · San Diego, US
Helen Toni Jun · San Diego, US
David J. King · Belmont, GB

Key dates

Filing date	Feb 28, 2024
Grant date	Oct 29, 2024
Priority date	—
Expiry date	Feb 28, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are antibodies and antigen binding fragments thereof that bind to human interleukin-11 receptor subunit α (IL-11Rα) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers, inflammatory diseases, autoimmune diseases, and others.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.